Having trouble accessing articles? Reset your cache.

FDA issues guidance on antibiotics for cIAI

FDA issued draft guidance on the development of drugs to treat complicated intra-abdominal infection (cIAI). The agency recommended the use of active-controlled, non-inferiority Phase

Read the full 243 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE